Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

FORT LEE, NJ - Nuvectis Pharma , Inc. (NASDAQ:NVCT), a biopharmaceutical company specializing in precision oncology medicines with a current market capitalization of $131 million, announced today its ...

Nuvectis Pharma, Inc. (Nasdaq: NVCT), a clinical-stage biopharmaceutical company focused on the development of innovative ...

February 4, 2025, marks World Cancer Day, a global initiative to raise awareness about the impact of cancer, encourage early detection, and support advancements in treatment. Cancer is a battle that ...

On the notable occasion of World Cancer Day 2025, let’s celebrate Bollywood celebrities who bravely fought and triumphed over ...

Dr. Scott Kamelle MILWAUKEE, WI, UNITED STATES, January 31, 2025 /EINPresswire / -- Milwaukee, WI – Dr. Scott Kamelle , a dedicated Gynecologi ...

A study shows AI models improve ovarian carcinoma subtyping, offering higher accuracy and efficiency for clinical diagnosis.

Gameto claims its Fertilo iPSC system can mature eggs outside the body using 80% fewer hormonal injections than typical methods.

Ovarian cancer is the deadliest gynecologic malignancy globally and is increasing in incidence and mortality with currently ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Their study showed that DCIS patients with pathogenic variants in BRCA1/2 and PALB2 had a higher risk of developing invasive breast cancer than those without.